Line Labbé

956 total citations
21 papers, 747 citations indexed

About

Line Labbé is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health and Virology. According to data from OpenAlex, Line Labbé has authored 21 papers receiving a total of 747 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Pediatrics, Perinatology and Child Health and 5 papers in Virology. Recurrent topics in Line Labbé's work include HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Line Labbé is often cited by papers focused on HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Line Labbé collaborates with scholars based in Canada, United States and France. Line Labbé's co-authors include Jacques Turgeon, Bettina A. Hamelin, Marc Pfister, John W. Mellors, Kara Bennett, Susan L. Rosenkranz, Lewis B. Sheiner, Scott M. Hammer, Nicolas Robitaille and Richard B. Pollard and has published in prestigious journals such as The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy and Critical Care Medicine.

In The Last Decade

Line Labbé

19 papers receiving 712 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Line Labbé Canada 14 355 255 173 132 113 21 747
Rubin Lubomirov Spain 13 374 1.1× 239 0.9× 162 0.9× 132 1.0× 128 1.1× 38 717
Thomas R. MacGregor United States 19 695 2.0× 487 1.9× 171 1.0× 148 1.1× 151 1.3× 46 1.3k
William D. Fiske United States 11 309 0.9× 209 0.8× 99 0.6× 90 0.7× 83 0.7× 17 544
Gary J. Muirhead United Kingdom 17 356 1.0× 264 1.0× 133 0.8× 130 1.0× 204 1.8× 25 1.7k
Daniel Röshammar Sweden 12 264 0.7× 149 0.6× 113 0.7× 78 0.6× 72 0.6× 22 564
Robin DiFrancesco United States 18 538 1.5× 298 1.2× 79 0.5× 101 0.8× 204 1.8× 53 968
A M Taburet France 19 239 0.7× 81 0.3× 95 0.5× 129 1.0× 236 2.1× 31 709
Catherine Gillotin France 15 278 0.8× 171 0.7× 112 0.6× 72 0.5× 86 0.8× 26 616
Belle L. Lee United States 12 438 1.2× 204 0.8× 154 0.9× 102 0.8× 142 1.3× 15 835
Scott D. Studenberg United States 12 241 0.7× 122 0.5× 76 0.4× 186 1.4× 153 1.4× 14 530

Countries citing papers authored by Line Labbé

Since Specialization
Citations

This map shows the geographic impact of Line Labbé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Line Labbé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Line Labbé more than expected).

Fields of papers citing papers by Line Labbé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Line Labbé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Line Labbé. The network helps show where Line Labbé may publish in the future.

Co-authorship network of co-authors of Line Labbé

This figure shows the co-authorship network connecting the top 25 collaborators of Line Labbé. A scholar is included among the top collaborators of Line Labbé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Line Labbé. Line Labbé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yue, Corinne Seng, Keith Gallicano, Line Labbé, & Murray P. Ducharme. (2013). Novel Population Pharmacokinetic Method Compared to the Standard Noncompartmental Approach to Assess Bioequivalence of Iron Gluconate Formulations. Journal of Pharmacy & Pharmaceutical Sciences. 16(3). 424–424. 2 indexed citations
2.
Kassir, Nastya, Line Labbé, Jean‐Romain Delaloye, et al.. (2013). Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in paediatric liver transplant recipients. British Journal of Clinical Pharmacology. 77(6). 1051–1063. 22 indexed citations
3.
Delaloye, Jean‐Romain, Nastya Kassir, Anne‐Laure Lapeyraque, et al.. (2011). Limited Sampling Strategies for Monitoring Tacrolimus in Pediatric Liver Transplant Recipients. Therapeutic Drug Monitoring. 33(4). 380–386. 8 indexed citations
4.
Hamelin, Bettina A., et al.. (2010). Increased Risk of Myocardial Infarction Associated With Angiotensin-Converting Enzyme Gene Polymorphism Is Age Dependent. The Journal of Clinical Pharmacology. 51(9). 1286–1292. 20 indexed citations
5.
Mouksassi, Samer, et al.. (2009). Population pharmacokinetics of intravenous pantoprazole in paediatric intensive care patients. British Journal of Clinical Pharmacology. 67(2). 216–227. 19 indexed citations
6.
Hadjadj, Samy, Pierre‐Jean Saulnier, F. Torremocha, Line Labbé, & R. Maréchaud. (2008). To what extent should we lower HbA1c in diabetic subjects?. Diabetes & Metabolism. 34. 37–40.
7.
Motsinger‐Reif, Alison A., Marylyn D. Ritchie, Robert W. Shafer, et al.. (2006). Multilocus genetic interactions and response to efavirenz-containing regimens: an Adult AIDS Clinical Trials Group study. Pharmacogenetics and Genomics. 16(11). 837–845. 50 indexed citations
8.
Michaud, Véronique, Samer Mouksassi, Line Labbé, et al.. (2006). Inhibitory Effects of Propafenone on the Pharmacokinetics of Caffeine in Humans. Therapeutic Drug Monitoring. 28(6). 779–783. 6 indexed citations
9.
Labbé, Line & Davide Verotta. (2006). A Non-linear Mixed Effect Dynamic Model Incorporating Prior Exposure and Adherence to Treatment to Describe Long-term Therapy Outcome in HIV-patients. Journal of Pharmacokinetics and Pharmacodynamics. 33(4). 519–542. 16 indexed citations
10.
Kenna, Leslie A., Line Labbé, Jeffrey S. Barrett, & Marc Pfister. (2005). Modeling and simulation of adherence: Approaches and applications in therapeutics. The AAPS Journal. 7(2). E390–E407. 32 indexed citations
11.
Haas, David W., Laura Smeaton, Robert W. Shafer, et al.. (2005). Pharmacogenetics of Long‐Term Responses to Antiretroviral Regimens Containing Efavirenz and/or Nelfinavir: An Adult AIDS Clinical Trials Group Study. The Journal of Infectious Diseases. 192(11). 1931–1942. 205 indexed citations
12.
Fauré, Christophe, Catherine Litalien, Yves Théorêt, et al.. (2005). THERAPEUTIC FAILURE OF A SINGLE INTRAVENOUS DOSE OF PANTOPRAZOLE IN YOUNG INTENSIVE CARE CHILDREN.. Critical Care Medicine. 33. A170–A170. 1 indexed citations
13.
Pfister, Marc, Line Labbé, Jianfeng Lü, et al.. (2002). Effect of coadministration of nelfinavir, indinavir, and saquinavir on the pharmacokinetics of amprenavir. Clinical Pharmacology & Therapeutics. 72(2). 133–141. 21 indexed citations
14.
Léauté‐Labrèze, C., et al.. (2002). [Blood pressure monitoring in infants with hemangiomas treated with corticosteroids].. PubMed. 129(2). 183–5. 8 indexed citations
15.
Pfister, Marc, Line Labbé, Scott M. Hammer, et al.. (2002). Population Pharmacokinetics and Pharmacodynamics of Efavirenz, Nelfinavir, and Indinavir: Adult AIDS Clinical Trial Group Study 398. Antimicrobial Agents and Chemotherapy. 47(1). 130–137. 110 indexed citations
16.
Lessard, Étienne, Marie‐Andrée Yessine, Bettina A. Hamelin, et al.. (2001). Diphenhydramine Alters the Disposition of Venlafaxine Through Inhibition of CYP2D6 Activity in Humans. Journal of Clinical Psychopharmacology. 21(2). 175–184. 57 indexed citations
17.
Labbé, Line, Caroline Sirois, Sylvie Pilote, et al.. (2000). Effect of gender, sex hormones, time variables and physiological urinary pH on apparent CYP2D6 activity as assessed by metabolic ratios of marker substrates.. Pharmacogenetics. 10(5). 425–438. 89 indexed citations
18.
Labbé, Line, et al.. (1999). Stereoselective Disposition of the Antiarrhythmic Agent Mexiletine During the Concomitant Administration of Caffeine. Therapeutic Drug Monitoring. 21(2). 191–199. 14 indexed citations
19.
Lessard, Étienne, et al.. (1999). Involvement of CYP2D6 activity in the N-oxidation of procainamide in man. Pharmacogenetics and Genomics. 9(6). 683–696. 34 indexed citations
20.
Bogaty, Peter, Susan Solymoss, L Boyer, et al.. (1998). Atherogenic, hemostatic, and other potential risk markers in subjects with previous isolated myocardial infarction compared with long-standing uncomplicated stable angina. American Heart Journal. 136(5). 884–893. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026